Cullen Frost Bankers Inc. Purchases 3,450 Shares of Intuitive Surgical, Inc. $ISRG

Cullen Frost Bankers Inc. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.4% in the third quarter, Holdings Channel.com reports. The firm owned 82,056 shares of the medical equipment provider’s stock after acquiring an additional 3,450 shares during the period. Cullen Frost Bankers Inc.’s holdings in Intuitive Surgical were worth $36,698,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Tobam boosted its stake in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical in the second quarter valued at approximately $27,000. Princeton Global Asset Management LLC bought a new position in Intuitive Surgical in the second quarter valued at approximately $30,000. Riggs Asset Managment Co. Inc. grew its holdings in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after acquiring an additional 32 shares during the period. Finally, First Command Advisory Services Inc. grew its holdings in Intuitive Surgical by 3,750.0% during the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 75 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Raymond James Financial raised their price target on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday. Royal Bank Of Canada increased their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. The Goldman Sachs Group restated a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a report on Friday, January 9th. Robert W. Baird lowered their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday. Finally, Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $617.57.

Insider Transactions at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. The trade was a 37.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 55,714 shares of company stock worth $31,617,799. Company insiders own 0.70% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q4 results beat Wall Street: Revenue and adjusted EPS topped estimates, backed by higher procedure volumes and system demand — a primary near‑term driver of recurring instrument sales. Reuters: Intuitive Surgical beats quarterly estimates on demand for surgical robots
• Positive Sentiment: Analysts boost some targets and reaffirm conviction: Bernstein raised its target sharply (big upside), Raymond James and BTIG reaffirmed/outperform with higher targets — supporting upside potential from elongation of the company’s growth runway. Benzinga: Analysts revise forecasts after Q4
• Neutral Sentiment: Guidance is measured: Management expects mid‑teens da Vinci procedure growth (midpoint ~14%) and 2026 gross margin around 67–68%, while flagging higher operating expenses for R&D — signaling steady growth but potential margin/operating‑leverage moderation. MarketBeat: Intuitive Surgical Just Proved the Growth Engine Still Runs
• Neutral Sentiment: JURA clinical update and milestone PRs add long‑term optionality: Early imaging data from the JURA feasibility study and a new 20 million‑patient da Vinci milestone reinforce long‑term growth narratives beyond core platforms. TipRanks: JURA feasibility study update GlobeNewswire: 20 Million Patients Benefit from da Vinci Surgery
• Negative Sentiment: Tariffs and gross‑margin pressure noted: Management expects tariffs to cut gross margins (about a 1.2% headwind in 2026) and flagged some gross‑margin decline vs. recent quarters — a medium‑term profitability risk. Zacks: Q4 beat but gross margin declines
• Negative Sentiment: Mixed analyst moves and a few downgrades: Some firms trimmed targets or moved to in‑line/hold (Evercore, Zacks), creating near‑term debate over valuation vs. growth and muting upside for traders focused on short‑term catalysts. The Fly: Evercore lowers price target

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $523.99 on Friday. The stock has a market cap of $187.84 billion, a price-to-earnings ratio of 66.41, a PEG ratio of 4.26 and a beta of 1.67. The business has a 50 day simple moving average of $562.32 and a 200 day simple moving average of $511.68. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.18%. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.